Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nuwellis, Inc.NUWE · Entity 8478 | Director | April 28, 2026 | April 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nuwellis, Inc.
Report date April 28, 2026 · Filed April 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Nonstatutory Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.16 · Expires 2036-04-27 | Direct | 6,744 |
Reported balance
After 2026-04-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-28 · Grant · Acquired 6,744 · Balance 6,744 F1: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2026 Filed Apr 29, 2026 21:16 UTC | Nuwellis, Inc. NUWE · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 6,744 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001140361-26-017868 · form4.xml · derivative · entry 1 McDonald David · CIK 0001455136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,744 Underlying: Common Stock · 6,744 shares Expires 2036-04-27 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:59 UTC | Nuwellis, Inc. NUWE · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 17,496 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0001455136-25-000002 · primary_doc.xml · derivative · entry 1 McDonald David · CIK 0001455136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,496 Underlying: Common Stock · 17,496 shares Expires 2035-05-19 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:21 UTC | Nuwellis, Inc. NUWE · Entity 8478 | GrantNonstatutory Stock Option (right to buy) · Derivative | 11,365 | $0.00 Strike: $0.69 | $0.00 |
DisclosureSEC source: 0001500842-24-000002 · primary_doc.xml · derivative · entry 1 McDonald David · CIK 0001455136 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,365 Underlying: Common Stock · 11,365 shares Expires 2034-01-01 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date that he was appointed to the Board of Directors (11/01/2023), so that all of the options will be vested on the one-year anniversary of the date that he was appointed to the Board of Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.